MedicinesFAQ

Econasil Uses, Dosage, Side Effects and more

Econasil is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).

Attribute Details
Trade Name Econasil
Generic Zagotenemab
Type Cream
Groups Investigational
Therapeutic Class
Manufacturer
Available Country United States
Last Updated: January 7, 2025 at 1:49 am
   

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.